NEW YORK--(BUSINESS WIRE)--New York Pharma Forum (NYPF) held its 22nd Annual General Assembly and annual meeting in New York on December 2nd.
Speaking on “The Genomics Revolution: Cancer and Beyond,” were:
•Dr. Steven Averbuch: Vice President, Early Global Clinical Research Oncology, Head of Pharmacodiagnostics, Bristol-Myers Squibb Company •Dr. Thomas Lynch, Jr.: Director of Yale Cancer Center; Physician-in-Chief, Smilow Cancer Hospital, Yale-New Haven Hospital; Richard and Jonathan Sackler Professor of Internal Medicine •Dr. Joseph McCracken: Global Head of Business Development & Licensing, Roche Pharma Partnering
Speaking on “The Genomics Revolution: Cancer and Beyond,” were:
•Dr. Steven Averbuch: Vice President, Early Global Clinical Research Oncology, Head of Pharmacodiagnostics, Bristol-Myers Squibb Company •Dr. Thomas Lynch, Jr.: Director of Yale Cancer Center; Physician-in-Chief, Smilow Cancer Hospital, Yale-New Haven Hospital; Richard and Jonathan Sackler Professor of Internal Medicine •Dr. Joseph McCracken: Global Head of Business Development & Licensing, Roche Pharma Partnering
